2-222694364-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_058165.3(MOGAT1):āc.481C>Gā(p.Leu161Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000561 in 1,604,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_058165.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152086Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000414 AC: 1AN: 241362Hom.: 0 AF XY: 0.00000765 AC XY: 1AN XY: 130780
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1452280Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 721786
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152086Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | The c.481C>G (p.L161V) alteration is located in exon 4 (coding exon 4) of the MOGAT1 gene. This alteration results from a C to G substitution at nucleotide position 481, causing the leucine (L) at amino acid position 161 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at